Issue 54, 2020

Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release

Abstract

In this work, bovine serum albumin-based nanoparticles, BSA-ACVA-DOX NPs, were fabricated for ultrasound-driven drug release, and exhibited excellent tissue penetration. Moreover, a pulsatile release of DOX in vivo could be programmed by in vitro (i.e., remotely) switching the ultrasound on and off.

Graphical abstract: Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release

Supplementary files

Article information

Article type
Communication
Submitted
14 Mar 2020
Accepted
20 May 2020
First published
05 Jun 2020

Chem. Commun., 2020,56, 7503-7506

Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release

J. Du, Y. Zhang, H. Ge, C. Shi, S. Long, W. Sun, J. Fan and X. Peng, Chem. Commun., 2020, 56, 7503 DOI: 10.1039/D0CC01937B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements